12/14/2017 - 11:50 AM EST 6:54
Tetra Bio-Pharma is focused on cannabinoid drug development and has a few products in the pipeline right now. We hear from Bernard Fortier, CEO of Tetra Bio-Pharma, on challenges and the process of getting a marijuana product prescription approved.
Tetra Bio-Pharma (TSX-V:TBP)(OTC:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development Canada
https://finance.yahoo.com/quote/TBP.V/
https://finance.yahoo.com/quote/TBPMF/
http://www.tetrabiopharma.com/home/default.aspx